Novozymes A/S (NSIS-B.CO)

DKK 409.4

(-0.8%)

EBITDA Summary of Novozymes A/S

  • Novozymes A/S's latest annual EBITDA in 2023 was 5.47 Billion DKK , up 1.05% from previous year.
  • Novozymes A/S's latest quarterly EBITDA in 2024 Q2 was 1.12 Billion DKK , up 0.0% from previous quarter.
  • Novozymes A/S reported an annual EBITDA of 6.11 Billion DKK in 2022, up 12.16% from previous year.
  • Novozymes A/S reported an annual EBITDA of 5.15 Billion DKK in 2021, up 7.4% from previous year.
  • Novozymes A/S reported a quarterly EBITDA of 1.12 Billion DKK for 2024 Q1, up 7.94% from previous quarter.
  • Novozymes A/S reported a quarterly EBITDA of 1.26 Billion DKK for 2023 Q1, up 13.14% from previous quarter.

Annual EBITDA Chart of Novozymes A/S (2023 - 2013)

Historical Annual EBITDA of Novozymes A/S (2023 - 2013)

Year EBITDA EBITDA Growth
2023 5.47 Billion DKK 1.05%
2022 6.11 Billion DKK 12.16%
2021 5.15 Billion DKK 7.4%
2020 4.85 Billion DKK 4.71%
2019 4.58 Billion DKK -10.14%
2018 5.1 Billion DKK 0.26%
2017 5.08 Billion DKK 3.27%
2016 4.92 Billion DKK -0.79%
2015 4.96 Billion DKK 20.45%
2014 4.12 Billion DKK 14.59%
2013 3.59 Billion DKK 0.0%

Peer EBITDA Comparison of Novozymes A/S

Name EBITDA EBITDA Difference
Flügger group A/S 236.36 Million DKK -2214.65%
Hove A/S 11.16 Million DKK -48903.867%
SP Group A/S 455.65 Million DKK -1100.679%